Cancer Research News: September 28 – October 11

The older cancer survivor population is predicted to increase substantially, an estimated 42% over the next decade.
Nature reports that draft guidelines for nanomedicine are being developed and that with hundreds of nanoproducts currently being tested in humans, the recommendations aim to safeguard trial participants.
A Conversation with Dr. Jane Perlmutter about the Role of Advocates in Cancer Research.
Open-access R&D could be one answer to drug industry woes.
The New York Times takes on the controversy of prostate cancer screening.

Cancer Research News: September 14 – September 27

Purdue technology was used in the first fluorescence-guided cancer surgery.
PSCA, a gene strongly associated with bladder and prostate cancer, appears to have been selected in populations of African ancestry, along with three other genes that are known to improve resistance to malaria.
Kathy L. Hudson, NIH deputy director, writes about Genomics, Health Care, and Society in the New England Journal of Medicine.
AACR releases a landmark Cancer Progress Report of 2011.

UN Summit reports that an estimated 2.8 million new cancer cases each year are linked to poor diet, lack of physical activity, and obesity.
Fred Hutchinson Cancer Research Center scientists have discovered blood proteins that are associated with early lung cancer development, which may eventually lead to a blood test for early diagnosis.
Dana Farber Cancer Institute researchers have identified a fused gene found in some colorectal tumors.